The Capital Tape, 2023–2025.
Public-company M&A is running flat; 29% of disclosed capital now sits with ten buyers (+8.2 pts vs the prior window), even as 2,206 buyers in the universe deployed $1.8T across 5,936 disclosed transactions.
Disclosed M&A capital
$1.8T
5,936 recorded transactions, 2023–2025
Active buyers
2,206
63% of the 3,507-buyer universe
Top-10 share of capital
29%
Ten buyers, $542.6B of disclosed capital
Median ticket
$36M
5,379 disclosed-and-counted transactions
The cycle in one number.
Capital, cadence, and ticket distribution moved within roughly one-third of the prior window.
$1.8T deployed by 2,206 buyers, within one-third of the prior 3-year window on every dimension that matters.
Read it as a ratio. Capital is what got spent; cadence is how many checks got cut; tickets are how big each was. When two of those three move sharply against the third, the cycle has a character, and the cycle character drives who you call next.
- Disclosed M&A capital$1.8T$1.6T+18%
- Recorded transactions5,9366,022flat
- Active buyers2,2062,070+7%
- Mean ticket (count-disclosed)$288M$241M+20%
- Buyer-universe penetration62.9%59.0%+7%
Recent = 2023–2025 · Prior = 2020–2022 · 10-K acquirer profiles, audited.
The capital tape.
The twenty-five public buyers writing the largest disclosed M&A checks in 2023–2025. Ranked by aggregate disclosed spend, with the prior 3-yr window as the comparable.
| # | Buyer | Market | Spend (2023–2025) | Spend (2020–2022) | Δ | Buys | Avg ticket | Share | Cum. | Archetype |
|---|---|---|---|---|---|---|---|---|---|---|
| 01 | Hdfc Bank Ltd.HDB | Regional Banking | $126.1B | N/A | disclosed | 1 | $126.1B | 6.8% | 7% | Horizontal Consolidation |
| 02 | J P Morgan Chase & Co.JPM | Financial Infrastructure | $81.8B | N/A | disclosed | 2 | $40.9B | 4.4% | 11% | Geographic Expansion |
| 03 | Microsoft CorporationMSFT | Software & IT | $75.4B | $29.3B | +158% | 1 | $75.4B | 4.1% | 15% | Platform |
| 04 | First Citizens Bancshares Inc.FCNCA | Regional Banking | $72.6B | $6B | +999% | 2 | $36.3B | 3.9% | 19% | Geographic Expansion |
| 05 | Broadcom Inc.AVGO | Semis & Hardware | $51.8B | $11.1B | +366% | 7 | $7.4B | 2.8% | 22% | Horizontal Consolidation |
| 06 | UnitedHealth Group IncorporatedUNH | Healthcare | $28.1B | $33.4B | −16% | N/A | N/A | 1.5% | 24% | Platform |
| 07 | Oracle CorporationORCL | Software & IT | $27.7B | $272M | disclosed | N/A | N/A | 1.5% | 25% | Bolt On |
| 08 | Amgen Inc.AMGN | Healthcare | $26.7B | $4.9B | +446% | 1 | $26.7B | 1.4% | 27% | Platform |
| 09 | Cisco Systems, Inc.CSCO | Connectivity | $26.6B | $7.8B | +242% | 5 | $5.3B | 1.4% | 28% | Horizontal Consolidation |
| 10 | Nasdaq OMX Group, Inc.NDAQ | Financial Infrastructure | $25.8B | $2.6B | +881% | 3 | $8.6B | 1.4% | 29% | Bolt On |
| 11 | Home Depot, Inc.HD | Consumer Products | $24.6B | $429M | disclosed | 1 | $24.6B | 1.3% | 31% | Geographic Expansion |
| 12 | International Paper Co.IP | Chemicals & Materials | $19.8B | $83M | disclosed | 2 | $9.9B | 1.1% | 32% | Geographic Expansion |
| 13 | AbbVie Inc.ABBV | Healthcare | $18B | $39.1B | −54% | 1 | $18B | 1.0% | 33% | Platform |
| 14 | CVS Health CorporationCVS | Healthcare | $17.1B | $285M | disclosed | 3 | $5.7B | 0.9% | 34% | Platform |
| 15 | Harris Corp.LHX | A&D Components | $13.4B | N/A | disclosed | N/A | N/A | 0.7% | 34% | Geographic Expansion |
| 16 | Bunge Global SABG | N/A | $13B | N/A | disclosed | 6 | $2.2B | 0.7% | 35% | Bolt On |
| 17 | Fifth Third BancorpFITB | Regional Banking | $12.7B | $3.6B | +252% | 1 | $12.7B | 0.7% | 36% | Horizontal Consolidation |
| 18 | Salesforce, Inc.CRM | Software & IT | $12.1B | $16.6B | −27% | 7 | $1.7B | 0.7% | 36% | Bolt On |
| 19 | Honeywell International IncHON | N/A | $11.8B | $1.8B | +569% | 8 | $1.5B | 0.6% | 37% | Bolt On |
| 20 | CARRIER GLOBAL CorpCARR | E&C | $11.3B | $872M | +999% | 1 | $11.3B | 0.6% | 38% | Geographic Expansion |
| 21 | Oneok Inc.OKE | Energy Infrastructure | $10.9B | N/A | disclosed | 6 | $1.8B | 0.6% | 38% | Geographic Expansion |
| 22 | Thermo Fisher Scientific Inc.TMO | Life Sciences | $10.8B | $19.5B | −44% | 2 | $5.4B | 0.6% | 39% | Bolt On |
| 23 | Amcor plcAMCR | Chemicals & Materials | $10.6B | $5.2B | +102% | 2 | $5.3B | 0.6% | 39% | Horizontal Consolidation |
| 24 | QXO, Inc.QXO | Industrial Services | $10.6B | $646M | +999% | 2 | $5.3B | 0.6% | 40% | Talent Acquisition |
| 25 | Intercontinental Exchange, Inc.ICE | Financial Infrastructure | $10.3B | $9.6B | +7% | 1 | $10.3B | 0.6% | 41% | Horizontal Consolidation |
| Top-25 cumulative | $749.5B | $192.9B | 41% | |||||||
Spend is buyer-disclosed total of cash + aggregate consideration extracted from 10-Ks. Avg ticket = spend ÷ disclosed buys (where both are present). Tape state: expansion · compression · disclosure · steady/exit.
Cohort migration.
How the buyer cohort reshuffled between 2020–2022 and 2023–2025. 613 buyers crossed the active/inactive line in one direction or the other, roughly 28% of the active pool.
Durable
382- First Citizens Bancshares Inc.FCNCA
5 active years across the 6-yr window
OtherGeographic Expansion$72.6B - Broadcom Inc.AVGO
5 active years across the 6-yr window
OtherHorizontal Consolidation$51.8B - UnitedHealth Group IncorporatedUNH
6 active years across the 6-yr window
Medical - Healthcare PlansPlatform$28.1B - AbbVie Inc.ABBV
6 active years across the 6-yr window
OtherPlatform$18B - Warner Bros. Discovery, Inc.WBD
5 active years across the 6-yr window
OtherGeographic Expansion$100M - Astrazeneca PLCAZN
4 active years across the 6-yr window
Other$19M
Accelerating
170- Oracle CorporationORCL
$272M → $28B
Software - InfrastructureBolt On$27.7B - CVS Health CorporationCVS
$285M → $17B
Medical - Healthcare PlansPlatform$17.1B - Home Depot, Inc.HD
$429M → $25B
OtherGeographic Expansion$24.6B - Regal Beloit Corp.RRX
$126M → $5B
OtherHorizontal Consolidation$5.1B - Neogen Corp.NEOG
$103M → $3B
OtherBolt On$3.3B - Chart Industries Inc.GTLS
$283M → $9B
OtherBolt On$8.7B
Entering
233- Hdfc Bank Ltd.HDB
Zero disclosed capital in prior window; $126B this cycle
OtherHorizontal Consolidation$126.1B - J P Morgan Chase & Co.JPM
Zero disclosed capital in prior window; $82B this cycle
OtherGeographic Expansion$81.8B - Harris Corp.LHX
Zero disclosed capital in prior window; $13B this cycle
OtherGeographic Expansion$13.4B - Bunge Global SABG
Zero disclosed capital in prior window; $13B this cycle
OtherBolt On$13B - Oneok Inc.OKE
Zero disclosed capital in prior window; $11B this cycle
OtherGeographic Expansion$10.9B - Mobix Labs, Inc.MOBX
Zero disclosed capital in prior window; $10B this cycle
OtherTechnology Acquisition$9.5B
Receding
380- Warner Bros. Discovery, Inc.WBD
$42B prior → $100M recent
OtherGeographic Expansion$42.4B - Astrazeneca PLCAZN
$41B prior → $19M recent
Other$41.1B - T-Mobile US, Inc.TMUS
$41B prior → $4B recent
OtherGeographic Expansion$40.8B - At&t Inc.T
$36B prior → $4B recent
OtherHorizontal Consolidation$35.8B - Gilead Sciences, Inc.GILD
$28B prior → $4B recent
OtherTechnology Acquisition$27.6B - Danaher Corp.DHR
$22B prior → $0 recent
Medical - Diagnostics & ResearchTalent Acquisition$21.6B
Capital flow by market.
Where the cycle's capital concentrated and where it cooled, rolled up by SE-Cluster market wedge. Solid bar = recent 3-yr spend; dashed = prior 3-yr.
- $245.7BHdfc Bank Limited+238%251205↑9
- $217.7BMicrosoft Corporation+10%379588N/A
- $195BUnitedHealth Group Incorporated−23%391700↓2
- $186.1BJpmorgan Chase & Co.+90%186265↑2
- $145.2BTHE Home Depot, Inc.+42%325609N/A
- $118.8BBroadcom Inc.+33%191200↑1
- $92.5BRegal Rexnord Corp.+32%126308↑4
- $86.6BPPL Corporation+115%129214↑6
- $85.8BInternational Paper Company+7%128259↓1
- $68.3BBecton, Dickinson and Company−36%155182↓6
- $65.5BWESCO International, Inc.+65%157388↑4
- $58.6BCisco Systems, Inc.−52%9886↓9
Rank column shows movement in the league table; positive = climbed; markets marked emerging had no disclosed prior; fading had no disclosed recent.
Ticket dynamics.
The shape of disclosed deal size: where buyers wrote checks, then where they wrote them this cycle versus last. Where the median and the top decile diverge, the cycle is bifurcating.
Distribution markers: disclosed-and-counted tickets
- RecentPriorΔ
- P25$6M$7M−16%
- Median$36M$37Mflat
- Mean$288M$241M+20%
- P75$126M$117M+7%
- Top decile$409M$459M−11%
Tickets derived from per-buyer disclosed spend ÷ disclosed count, then weighted by transaction count for distribution percentiles. Sample sizes: 5,379 recent, 5,652 prior.
Tickets by band: share of recorded transactions
- < $25M+1.1 pts
- $25M – $100M-2.0 pts
- $100M – $500M+1.7 pts
- $500M – $2B-1.1 pts
- $2B – $10B+0.3 pts
- > $10B+0.0 pts
Bar = recent share; dashed underlay = prior share. Δ column reads as percentage-point shift in transaction distribution.
Largest single-year disclosed buyer-spend rows, 2023–2025
- $75.4BFY2024
- $67.9BFY2024
- $63.8BFY2024
- $62.3BFY2025
- $36.3BFY2023
- $36.3BFY2024
Strategy posture.
Spend-weighted strategy mix between 2020–2022 and 2023–2025. Buyers are weighted by disclosed capital, falling back to deal count when spend is undisclosed; the lines below capture how capital allocation is being framed, not just deal volume.
Mix shift: recent vs prior
Movers: biggest shifts
- +1.7 pts
Platform gained share
19% → 21% of spend-weighted strategy mix · largest writer: Hdfc Bank Ltd.
- -1.7 pts
Technology Acquisition yielded share
11% → 10% of spend-weighted strategy mix · largest writer: Microsoft Corporation
- +1.2 pts
Horizontal Consolidation gained share
17% → 18% of spend-weighted strategy mix · largest writer: Hdfc Bank Ltd.
- -1.1 pts
Tuck In yielded share
4% → 3% of spend-weighted strategy mix · largest writer: Home Depot, Inc.
The watch list.
Three short lists for the next call. The compounders are who will likely buy next; the emerging cohort is who's quietly building a program; the decelerators are the cap table or strategy alternatives candidates.
Programmatic compounders
Three or more active years, three or more disclosed buys, $500M+ deployed recent; these are the predictable engines.
- 01$52B
- 02Cisco Systems, Inc.CSCO$27B
3/3 active years · 5 disclosed buys · $27B deployed
Communication EquipmentHorizontal Consolidation - 03$26B
- 04CVS Health CorporationCVS$17B
3/3 active years · 3 disclosed buys · $17B deployed
Medical - Healthcare PlansPlatform - 05$13B
- 06$12B
Emerging acquirers
Quiet or absent in the prior window, now running multi-year cadence with $250M+ deployed.
- 01$126B
- 02J P Morgan Chase & Co.JPM$82B
First-cycle entrant · 2 active years · $82B deployed
OtherGeographic Expansion - 03$13B
- 04$13B
- 05$11B
- 06$10B
Decelerating writers
Material deployment in the prior window, now running at less than 40% of that pace, either paused or pivoting.
- 01Warner Bros. Discovery, Inc.WBD−100%
$42B prior → $100M recent · 1 disclosed buys this cycle
OtherGeographic Expansion - 02−100%
- 03−91%
- 04−90%
- 05Gilead Sciences, Inc.GILD−85%
$28B prior → $4B recent · 2 disclosed buys this cycle
OtherTechnology Acquisition - 06Danaher Corp.DHR−100%
$22B prior → $0 recent · 4 disclosed buys this cycle
Medical - Diagnostics & ResearchTalent Acquisition
Voice of the cycle.
The cycle's vocabulary, in the words buyers chose to file under penalty of disclosure. Filter by archetype to listen for the verbs each playbook uses.
“Our historical growth has included, and our future growth is likely to continue to include, in large part our acquisition strategy and the successful integration of acquired businesses into our existing operations.”
“Failure to implement our acquisition strategy, including successfully integrating acquired businesses, could have an adverse effect on our business, financial condition and results of operations.”
“We are actively seeking complementary bolt-on AI acquisitions that could generate near-term revenue to supplement our current operations”
“The M&A Rules, along with certain foreign exchange regulations discussed below, will be interpreted or implemented by the relevant government authorities in connection with our future offshore financings or acquisitions, and we cannot predict how they will affect our acquisition strategy.”
“fewer acquisition opportunities than NEP expects, which could result from, among other things, available projects having less desirable economic returns or higher risk profiles than NEP believes suitable for its acquisition strategy and future growth;”
“The Company believes the acquisition will be complementary to FOX’s Tuscany business, expanding its North American geographic manufacturing footprint and broadening its product offering in a growing segment of the automotive industry.”
Methodology & receipts.
Every figure here is sourced from EDGAR filings, extracted with the v6 audited corpus, and validated against a four-layer verification stack. The receipts below show what was filed, what was accepted, and what was quarantined.
Audit ledger
N/A
Of 0 fact-level checks, 0 were accepted and 0 were quarantined for downstream investigation.
The full ledger is browseable at /extractor/audit.
Disclosure tiers: what filers actually filed
- Count and spendN/A
Both dimensions filed.
- Count onlyN/A
Buys disclosed; spend not enumerated.
- Spend onlyN/A
Aggregate spend filed; count undisclosed.
- Not disclosedN/A
Issuer-year with no acquisition disclosure.
Computed across 0 issuer-fiscal-year rows in 0 audited acquirer profiles.
Universe coverage
- Public issuers indexed
- 42,370
- Public buyers ranked
- 3,507
- Markets fully decoded
- 20 / 20
- Recent-window active buyers
- 2,206
- Release tag
- N/A
- Snapshot generated
- N/A
No survey data, no proprietary scraping outside of EDGAR, no bought-in lists. Where the cycle disagrees with the file, the file wins.
Windowing: recent = 2023–2025, prior = 2020–2022. Spend is the buyer-disclosed total of cash and aggregate consideration extracted from 10-K acquisition disclosures. Strategy mix is spend-weighted, falling back to deal count at $25M per recorded buy when spend is undisclosed. Active = the buyer disclosed a count or spend in at least one year of the window. Concentration uses raw $MM deployed, not the count of buyers.